Guardant Health, Inc. , a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally.
Guardant Health stock last closed at $44.97, down 0.46% from the previous day, and has increased 174.37% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 2.02 percentage points. Guardant Health stock is currently +168.16% from its 52-week low of $16.77, and -11.63% from its 52-week high of $50.89.
As of Apr 17, 2025, there are 123.42M shares of GH outstanding. The market capitalization of GH is $5.55B. In the past 24 hours, 1.84M GH shares were traded.
How to Buy Guardant Health Stock
Wondering how to invest in Guardant Health stock? Here's how.
Decide where to buy Guardant Health stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Guardant Health stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Pick your method of payment and add your info.
Analyze Guardant Health stock: The Guardant Health ticker symbol is GH. Is Guardant Health stock a good investment? Should you buy shares of GH? How do GH's underlying business fundamentals look? Do top analysts think Guardant Health is a good buy? Why has GH's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if GH is a good stock to buy).
Execute your GH trade: Decide if you will purchase GH shares at the current market price or use a limit order to purchase GH stock at a given price.
Keep an eye on your GH position: Create a watchlist to monitor your investment in Guardant Health shares.
Step 1: Decide where to buy Guardant Health stock
You will need a brokerage account to access the NASDAQ market and buy GH stock.
A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Tech to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you are able to invest in GH stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Guardant Health stock
After you have decided on the best place to buy Guardant Health stock, it's absolutely critical to analyze their stock prior to buying, so you actually wrap your head around the risk and opportunity.
Guardant Health quick stats
GH Price
$44.97
1w %
9.31%
1y %
174.37%
5y %
-38.57%
P/E
-12.63x
P/B
-39.74x
P/S
7.47x
PEG
N/A
Revenue
$739.02M
Earnings
-$436.37M
Fore. Rev. Growth
19.89%
Fore. Earn. Growth
N/A
Market Cap
$5.55B
Next Earnings
Jun 12, 2025
Next Dividend
N/A
GH Overview
WallStreetZen was built to help everyday investors do better fundamental analysis.
You can see all of the due diligence checks on GH's stock page.
Is GH stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge GH's intrinsic value.
You can access additional valuation research on GH's stock here.
GH Financial Overview
Passed Health Checks:
GH has cash burn of 274943000. It has sufficient cash and short-term investments to cover this for at least one year.
GH has $944.19M in cash and short term investments. This is enough to cover its annual cash burn of $274.94M.
There are more short-term assets than short-term liabilities on the GH balance sheet.
Failed Health Checks:
Total GH debt is still negative.
There are more long-term liabilities than short-term assets on the GH balance sheet.
GH profit margin has gone up by 0.26 percentage points in the past year, but the company is still unprofitable.
GH debt to equity ratio of -11.64 is negative.
Do Wall Street analysts think it's a good time to buy Guardant Health stock
Out of 14 Equities analysts who research GH, the consensus analyst rating on Guardant Health is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest GH Analyst Ratings
Subbu Nambi, a bottom 12% analyst from Guggenheim reiterates GH with a strong buy rating and maintains their GH price target from $56.00 to $56.00, on Feb 24, 2025.
Sung Ji Nam, a bottom 6% analyst from ScotiaBank maintains GH with a buy rating and raises their GH price target from $47.00 to $52.00, on Feb 24, 2025.
Kyle Mikson, a bottom 4% analyst from Canaccord Genuity maintains GH with a strong buy rating and raises their GH price target from $42.00 to $60.00, on Feb 24, 2025.
Matthew Sykes, a top 7% analyst from Goldman Sachs maintains GH with a strong buy rating and raises their GH price target from $49.00 to $56.00, on Feb 21, 2025.
Andrew Cooper, a bottom 3% analyst from Raymond James reiterates GH with a buy rating and raises their GH price target from $39.00 to $59.00, on Feb 21, 2025.
Last year, GH revenue was $739.02M. In the past five year, GH's revenue has gone up by 28.08% per year. This was faster than the Diagnostics & Research industry average of 9.96%.
No, Guardant Health doesn't provide an income stream by paying out dividends.
What others are saying about GH
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your GH trade
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are mostly the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open button and your broker will place the order.
If you need additional help investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Guardant Health share?
As of Apr 17, 2025, it costs $44.97 to buy one share of Guardant Health stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.222 shares of GH.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.